Article info
PDFReview
Clinical trials in systemic lupus erythematosus: the dilemma—Why have phase III trials failed to confirm the promising results of phase II trials?
- Correspondence to Professor David Alan Isenberg, Department of Rheumatology, University College London, London WC1E 6BT, UK; d.isenberg{at}ucl.ac.uk
Citation
Clinical trials in systemic lupus erythematosus: the dilemma—Why have phase III trials failed to confirm the promising results of phase II trials?
Publication history
- Received May 24, 2022
- Accepted August 4, 2022
- First published October 6, 2022.
Online issue publication
May 25, 2023
Article Versions
- Previous version (23 January 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.